Clinical Trials Logo

Hypertension clinical trials

View clinical trials related to Hypertension.

Filter by:

NCT ID: NCT05517915 Completed - Hypertension Clinical Trials

Inspiratory Muscle Training, Autonomic Dysfunction and Blood Pressure

Start date: January 8, 2018
Phase: N/A
Study type: Interventional

This study finds the effectiveness of inspiratory muscle threshold loading training among adults with hypertension. A sample of hypertensive subjects was divided into two groups - inspiratory muscle training (IMT) - group (inspiratory muscle training was prescribed) and sham-group (no load was prescribed during IMT). Both groups had training sessions comprising seven cycles of two minutes bouts of breathing counter to an inspiratory load, each bout parted by one minute of unloaded recovery. Treatment session was performed for three times per week for a total of six weeks. Measurement of each of the variables (blood pressure, resting heart rate (RHR), heart rate variability (HRV)) was taken at baseline and after the six-week intervention.

NCT ID: NCT05517512 Completed - Clinical trials for Gestational Hypertension

Relation Between Protein 13 and Gestational Hypertensive Disorder

Start date: March 12, 2020
Phase:
Study type: Observational

the attendants of the clinic with a one-missed period (T0) underwent determination of baseline blood pressure (BP) measures and gave blood samples for estimation of levels of placental growth factor (PLGF), soluble fms-like tyrosine kinase-1 (sFlt-1) and pregnancy protein 13 (PP13). The same evaluation was repeated on the 6th, 24th, 32nd, and 36th gestational week (GW). Twenty non-pregnant women gave samples as a negative control group.

NCT ID: NCT05516173 Recruiting - Hypertension Clinical Trials

Role of Depression in Blood Pressure Control. Study

TUN-BP-BLUE
Start date: August 15, 2022
Phase:
Study type: Observational

Our study aims to evaluate the role of depression in blood pressure control in ambulatory hypertensive patients.

NCT ID: NCT05513937 Completed - Hypertension Clinical Trials

Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy

Botticelli
Start date: May 12, 2022
Phase: Phase 4
Study type: Interventional

Study to assess the anti-hypertensive efficacy and safety of the extemporaneous combination of Nebivolol 5 mg in combination with Amlodipine 5 mg or AML 10 mg in lowering the sitting diastolic BP after 8 weeks of treatment inpatients with uncontrolled BP previously treated with Nebivolol (NEB) or Amlodipine (5 mg) monotherapies for at least 4 weeks.

NCT ID: NCT05513430 Completed - Clinical trials for Hypertension,Essential

Pharmacological and Nonpharmacological Factors That Contribute Blood Pressure Control

Start date: June 16, 2014
Phase:
Study type: Observational

Study is an observational study among hypertensive patients

NCT ID: NCT05512624 Recruiting - Hypertension Clinical Trials

Integrating a Mental Health Intervention Into Primary Health Care for Refugees

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the impact of an evidence-based mental health intervention (Common Elements Treatment Approach) on medication adherence, behavioral improvement and clinical outcomesamong adults taking medication for hypertension, diabetes and epilepsy using a two-arm randomized wait-list controlled trial among adult refugees in Mae La camp, Thailand.

NCT ID: NCT05512143 Not yet recruiting - Hypertension Clinical Trials

TMS for PTSD and Blood Pressure

Start date: February 15, 2024
Phase: N/A
Study type: Interventional

In this randomized clinical trial, we will test the short and longer term effects of repetitive transcranial magnetic stimulation (TMS) on blood pressure among reproductive aged female participants with elevated symptoms of post-traumatic stress disorder and hypertension.

NCT ID: NCT05508633 Not yet recruiting - Portal Hypertension Clinical Trials

The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an Exploratory Pilot Study

Start date: August 2022
Phase: Phase 2
Study type: Interventional

The main purpose of this exploratory study was to investigate the instant efficacy and safety of alverine oral administration in decreasing portal hypertension. Condition of disease: Cirrhotic portal hypertension Intervention/treatment: Drug: Alverine 60 mg (1 capsule), orally Drug: Alverine 120 mg (2 capsules), orally

NCT ID: NCT05506800 Suspended - Breast Cancer Clinical Trials

Guangzhou Women's Health Cohort Study (GWHCS)

Start date: March 3, 2016
Phase:
Study type: Observational

The Guangzhou Women's Health Cohort Study aims to explore the health trajectory and factors contributing to the health of women aged 35-64 in Guangzhou. Based on multiple population health registration data platforms, data of the cohort will provide information about the health of women across the lifespan, facilitating the decision-making process by local government . The cohort is progressing steadily, and the goal is to build a large women cohort covering 11 administrative districts of Guangzhou with a scale of 1 million by 2030.

NCT ID: NCT05503953 Not yet recruiting - Clinical trials for Essential Hypertension

Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS

Start date: September 5, 2022
Phase: Phase 3
Study type: Interventional

A multicenter, Randomized, Double-blind, Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients with Essential Hypertension Inadequately Controlled with AGLS